Having trouble accessing articles? Reset your cache.

Folotyn pralatrexate: Phase IIb data

Top-line data from an open-label, international Phase IIb trial in patients with stage IIIb/IV NSCLC who had received 1 or 2 prior systemic treatments, including at least 1 prior platinum-based regimen, showed that IV

Read the full 348 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE